|
Principal Investigator: Marianna Baum & Richard Marlink
Funding: NIH
Objectives:
A randomised, multifactorial, double-blind placebo controlled clinical trial to determine the efficacy of micronutrient therapy in improving immune function and preventing early mortality in HIV-1 infected adults whose CD4 count is >350 cells/mm3. A multifactorial design will compare the efficacy of multivitamins, or selenium, or the combination of multivitamins and selenium to a placebo supplementation.
Enrollment:
Enrollment Complete:
Follow Up:
close window
|